<code id='051FAC7DF5'></code><style id='051FAC7DF5'></style>
    • <acronym id='051FAC7DF5'></acronym>
      <center id='051FAC7DF5'><center id='051FAC7DF5'><tfoot id='051FAC7DF5'></tfoot></center><abbr id='051FAC7DF5'><dir id='051FAC7DF5'><tfoot id='051FAC7DF5'></tfoot><noframes id='051FAC7DF5'>

    • <optgroup id='051FAC7DF5'><strike id='051FAC7DF5'><sup id='051FAC7DF5'></sup></strike><code id='051FAC7DF5'></code></optgroup>
        1. <b id='051FAC7DF5'><label id='051FAC7DF5'><select id='051FAC7DF5'><dt id='051FAC7DF5'><span id='051FAC7DF5'></span></dt></select></label></b><u id='051FAC7DF5'></u>
          <i id='051FAC7DF5'><strike id='051FAC7DF5'><tt id='051FAC7DF5'><pre id='051FAC7DF5'></pre></tt></strike></i>

          explore

          explore

          author:comprehensive    Page View:7
          Adobe

          By some measures, private equity investment lagged in 2023, a year marked by growing distress and high-profile downfalls among private equity-backed health care companies.

          Even so, three sectors still managed to see strong deal flow and prices: med spa, cardiology, and clinical trial sites, according to a new PitchBook report analyzing private equity investments in health care services in 2023. Each of the three niches continue to generate buzz among investors, even as other areas fizzle.

          advertisement

          It’s not that those three industries are perfect fits for private equity, it’s that the more obvious areas like autism therapists and physician practices are struggling with high interest rates and regulatory scrutiny, said Rebecca Springer, PitchBook’s lead health care analyst.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Guidelines to prevent youth baseball injuries need more muscle
          Guidelines to prevent youth baseball injuries need more muscle

          Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem

          read more
          Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves
          Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

          MollyFerguson/STATThisweek,anencouragingturnaroundforOcularTherapeutix,achatwithAlnylam’sCEOdefendin

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Medicare inequities exacerbate Puerto Rico’s health disparities

          RamonEspinosa/APWhenIaccompanymyfathertohisregularcardiologistappointmentinPuertoRico,worryandsadnes